|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patard JJ, Leray E, Rioux-Leclercq N,
Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani
W, Abbou CC, et al: Prognostic value of histologic subtypes in
renal cell carcinoma: A multicenter experience. J Clin Oncol.
23:2763–2771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maher ER: Genomics and epigenomics of
renal cell carcinoma. Semin Cancer Biol. 23:10–17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rydzanicz M, Wrzesinski T, Bluyssen HA and
Wesoły J: Genomics and epigenomics of clear cell renal cell
carcinoma: Recent developments and potential applications. Cancer
Lett. 341:111–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jonasch E, Futreal PA, Davis IJ, Bailey
ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J,
et al: State of the science: An update on renal cell carcinoma. Mol
Cancer Res. 10:859–880. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen C and Kaelin WG Jr: The VHL/HIF axis
in clear cell renal carcinoma. Semin Cancer Biol. 23:18–25. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simon JM, Hacker KE, Singh D, Brannon AR,
Parker JS, Weiser M, Ho TH, Kuan PF, Jonasch E, Furey TS, et al:
Variation in chromatin accessibility in human kidney cancer links
H3K36 methyltransferase loss with widespread RNA processing
defects. Genome Res. 24:241–250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakada C, Tsukamoto Y, Matsuura K, Nguyen
TL, Hijiya N, Uchida T, Sato F, Mimata H, Seto M and Moriyama M:
Overexpression of miR-210, a downstream target of HIF1α, causes
centrosome amplification in renal carcinoma cells. J Pathol.
224:280–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: Significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Enfield KS, Pikor LA, Martinez VD and Lam
WL: Mechanistic roles of noncoding RNAs in lung cancer biology and
their clinical implications. Genet Res Int.
2012:7374162012.PubMed/NCBI
|
|
13
|
von Roemeling CA, Radisky DC, Marlow LA,
Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW and Copland JA:
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by
activating the AMPA-selective glutamate receptor-4. Cancer Res.
74:4796–4810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tun HW, Marlow LA, von Roemeling CA,
Cooper SJ, Kreinest P, Wu K, Luxon BA, Sinha M, Anastasiadis PZ and
Copland JA: Pathway signature and cellular differentiation in clear
cell renal cell carcinoma. PLoS One. 5:e106962010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eckel-Passow JE, Serie DJ, Bot BM, Joseph
RW, Cheville JC and Parker AS: ANKS1B is a smoking-related
molecular alteration in clear cell renal cell carcinoma. BMC Urol.
14:142014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y,
Ai Q, Zhang P, Song EL, Huang QB, et al: Downregulation of FOXO3a
promotes tumor metastasis and is associated with metastasis-free
survival of patients with clear cell renal cell carcinoma. Clin
Cancer Res. 20:1779–1790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao WJ, Wu HL, He BS, Zhang YS and Zhang
ZY: Analysis of long non-coding RNA expression profiles in gastric
cancer. World J Gastroenterol. 19:3658–3664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu G, Yao W, Wang J, Ma X, Xiao W, Li H,
Xia D, Yang Y, Deng K, Xiao H, et al: LncRNAs expression signatures
of renal clear cell carcinoma revealed by microarray. PLoS One.
7:e423772012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fachel AA, Tahira AC, Vilella-Arias SA,
Maracaja-Coutinho V, Gimba ER, Vignal GM, Campos FS, Reis EM and
Verjovski-Almeida S: Expression analysis and in silico
characterization of intronic long noncoding RNAs in renal cell
carcinoma: Emerging functional associations. Mol Cancer.
12:1402013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saitou M, Sugimoto J, Hatakeyama T, Russo
G and Isobe M: Identification of the TCL6 genes within the
breakpoint cluster region on chromosome 14q32 in T-cell leukemia.
Oncogene. 19:2796–2802. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin D, He X, Zhang E, Kong R, De W and
Zhang Z: Long noncoding RNA GAS5 affects cell proliferation and
predicts a poor prognosis in patients with colorectal cancer. Med
Oncol. 31:2532014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu ZQ, Li RJ, Mei JZ and Li XH:
Down-regulation of long non-coding RNA GAS5 is associated with the
prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol.
7:4303–4309. 2014.PubMed/NCBI
|
|
24
|
Pickard MR and Williams GT: Regulation of
apoptosis by long non-coding RNA GAS5 in breast cancer cells:
Implications for chemotherapy. Breast Cancer Res Treat.
145:359–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783.
2014.PubMed/NCBI
|
|
26
|
Morenos L, Chatterton Z, Ng JL, Halemba
MS, Parkinson-Bates M, Mechinaud F, Elwood N, Saffery R and Wong
NC: Hypermethylation and down-regulation of DLEU2 in paediatric
acute myeloid leukaemia independent of embedded tumour suppressor
miR-15a/16-1. Mol Cancer. 13:1232014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Graham LD, Pedersen SK, Brown GS, Ho T,
Kassir Z, Moynihan AT, Vizgoft EK, Dunne R, Pimlott L, Young GP, et
al: Colorectal neoplasia differentially expressed (CRNDE), a novel
gene with elevated expression in colorectal adenomas and
adenocarcinomas. Genes Cancer. 2:829–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui B, Chen L, Zhang S, Mraz M, Fecteau
JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, et al: MicroRNA-155
influences B-cell receptor signaling and associates with aggressive
disease in chronic lymphocytic leukemia. Blood. 124:546–554. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Michelhaugh SK, Lipovich L, Blythe J, Jia
H, Kapatos G and Bannon MJ: Mining Affymetrix microarray data for
long non-coding RNAs: Altered expression in the nucleus accumbens
of heroin abusers. J Neurochem. 116:459–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liao Q, Liu C, Yuan X, Kang S, Miao R,
Xiao H, Zhao G, Luo H, Bu D, Zhao H, et al: Large-scale prediction
of long non-coding RNA functions in a coding-non-coding gene
co-expression network. Nucleic Acids Res. 39:3864–3878. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou S, Wang J and Zhang Z: An emerging
understanding of long noncoding RNAs in kidney cancer. J Cancer Res
Clin Oncol. 140:1989–1995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mourtada-Maarabouni M, Pickard MR, Hedge
VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA,
controls apoptosis and is downregulated in breast cancer. Oncogene.
28:195–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ohno H: Pathogenetic role of BCL6
translocation in B-cell non-Hodgkin's lymphoma. Histol Histopathol.
19:637–650. 2004.PubMed/NCBI
|
|
37
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang Q, Chen J, Beezhold KJ, Castranova
V, Shi X and Chen F: JNK1 activation predicts the prognostic
outcome of the human hepatocellular carcinoma. Mol Cancer.
8:642009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pressinotti NC, Klocker H, Schäfer G, Luu
VD, Ruschhaupt M, Kuner R, Steiner E, Poustka A, Bartsch G and
Sültmann H: Differential expression of apoptotic genes PDIA3 and
MAP3K5 distinguishes between low- and high-risk prostate cancer.
Mol Cancer. 8:1302009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ooi A, Wong JC, Petillo D, Roossien D,
Perrier-Trudova V, Whitten D, Min BW, Tan MH, Zhang Z, Yang XJ, et
al: An antioxidant response phenotype shared between hereditary and
sporadic type 2 papillary renal cell carcinoma. Cancer Cell.
20:511–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cifola I, Spinelli R, Beltrame L, Peano C,
Fasoli E, Ferrero S, Bosari S, Signorini S, Rocco F, Perego R, et
al: Genome-wide screening of copy number alterations and LOH events
in renal cell carcinomas and integration with gene expression
profile. Mol Cancer. 7:62008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rager JE and Fry RC: The aryl hydrocarbon
receptor pathway: A key component of the microRNA-mediated AML
signalisome. Int J Environ Res Public Health. 9:1939–1953. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Broyl A, Hose D, Lokhorst H, de Knegt Y,
Peeters J, Jauch A, Bertsch U, Buijs A, Stevens-Kroef M, Beverloo
HB, et al: Gene expression profiling for molecular classification
of multiple myeloma in newly diagnosed patients. Blood.
116:2543–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Iosue I, Quaranta R, Masciarelli S,
Fontemaggi G, Batassa EM, Bertolami C, Ottone T, Divona M,
Salvatori B, Padula F, et al: Argonaute 2 sustains the gene
expression program driving human monocytic differentiation of acute
myeloid leukemia cells. Cell Death Dis. 4:e9262013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fu XL, Liu DJ, Yan TT, Yang JY, Yang MW,
Li J, Huo YM, Liu W, Zhang JF, Hong J, et al: Analysis of long
non-coding RNA expression profiles in pancreatic ductal
adenocarcinoma. Sci Rep. 6:335352016. View Article : Google Scholar : PubMed/NCBI
|
